{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:58:38Z","timestamp":1778029118380,"version":"3.51.4"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019179","name":"Fundacion La Caixa","doi-asserted-by":"publisher","award":["HR18-00452"],"award-info":[{"award-number":["HR18-00452"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FISPI17\/000809"],"award-info":[{"award-number":["FISPI17\/000809"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.neuroscience.2021.10.023","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T22:46:46Z","timestamp":1635547606000},"page":"119-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology"],"prefix":"10.1016","volume":"518","author":[{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica Jord\u00e1n","family":"Pirla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Torrej\u00f3n-Escribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2021.10.023_b0005","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-catenin is a target for the ubiquitin-proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease","volume":"163","author":"An","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0306-4522(95)00146-A","article-title":"Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen activated protein kinase in Alzheimer\u2019s disease","volume":"68","author":"Arendt","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0020","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnen\/60.12.1190","article-title":"Activation of the JNK\/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis","volume":"60","author":"Atzori","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2990.2006.00756.x","article-title":"Lysosome associated membrane protein 1 (LAMP-1) in Alzheimer\u2019s disease","volume":"32","author":"Barrachina","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0030","doi-asserted-by":"crossref","first-page":"35119","DOI":"10.1074\/jbc.M505895200","article-title":"Disease-related modifications in tau affect the interaction between Fyn and Tau","volume":"280","author":"Bhaskar","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0035","first-page":"641","article-title":"Sequestration of tau by granulovacuolar degeneration in Alzheimer\u2019s disease","volume":"139","author":"Bondareff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.58.4.589","article-title":"Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy","volume":"58","author":"Borghi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary tangles","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer's disease in individuals under thirty","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0070","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/brain\/awv236","article-title":"The preclinical phase of the pathological process underlying sporadic Alzheimer's disease","volume":"138","author":"Braak","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation, and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0085","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/labinvest.2011.149","article-title":"A novel origin for granulovacuolar degeneration in aging and Alzheimer\u2019s disease: parallels to stress granules","volume":"91","author":"Castellani","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/nen.0b013e3180303b93","article-title":"Neurofibrillary tangles may interfere with Smad 2\/3 signaling in neurons","volume":"66","author":"Chalmers","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0095","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1021\/acschemneuro.9b00190","article-title":"Changes in protein phosphorylation are associated with synaptic functions during the early stage of Alzheimer's disease","volume":"10","author":"Chen","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnen\/59.11.966","article-title":"Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study","volume":"59","author":"Chin","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pmic.201400189","article-title":"Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins","volume":"15","author":"Dammer","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00230483","article-title":"Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer\u2019s disease: localization of two amino terminal tau epitopes in GVB","volume":"85","author":"Dickson","year":"1993","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0115","doi-asserted-by":"crossref","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Safar J, Ueberheide N, Wisniewski T (2020) Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain 143:2803-2817.","DOI":"10.1093\/brain\/awaa223"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF03033283","article-title":"Stress kinases involved in tau phosphorylation in Alzheimer\u2019s disease, tauopathies and APP transgenic mice","volume":"6","author":"Ferrer","year":"2004","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia","volume":"97","author":"Ferrer","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0130","doi-asserted-by":"crossref","unstructured":"Ferrer I (2014) Brain banking. In: Aminoff MJ and Daroff RB, eds. Encyclopedia of the neurological sciences, 2nd edition, vol. 1. Academic Press, pp: 467-473.","DOI":"10.1016\/B978-0-12-385157-4.00585-6"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/nan.12618","article-title":"White matter alterations in Alzheimer\u2019s disease without concomitant pathologies","volume":"46","author":"Ferrer","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12996","article-title":"Dysregulated protein phosphorylation: a determining condition in the continuum of brain aging and Alzheimer\u2019s disease","volume":"31","author":"Ferrer","year":"2021","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-002-0587-8","article-title":"Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration","volume":"104","author":"Ferrer","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0150","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s007020100016","volume":"108","author":"Ferrer","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1750-3639.2001.tb00387.x","volume":"11","author":"Ferrer","year":"2001","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1567205052772713","article-title":"Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies","volume":"2","author":"Ferrer","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","article-title":"Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression","volume":"73","author":"Ferrer","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10561-008-9077-0","article-title":"Brain banks: benefits, limitations, and cautions concerning the use of post-mortem brain tissue for molecular studies","volume":"9","author":"Ferrer","year":"2008","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnins.2020.00068","article-title":"A connected network of interacting proteins is involved in human-tau toxicity in Drosophila","volume":"14","author":"Feuillette","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0180","article-title":"Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer\u2019s disease pathology","volume":"2012","author":"Funk","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0185","doi-asserted-by":"crossref","unstructured":"Funk KE, Mrak RE, Kuret J (2011) Granulovacuolar degeneration (GVD) bodies of Alzheimer\u2019s disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol 37:295-306.","DOI":"10.1111\/j.1365-2990.2010.01135.x"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00005072-198703000-00006","article-title":"Hirano body filaments contain actin and actin-associated proteins","volume":"46","author":"Galloway","year":"1987","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/JMN:25:1:079","article-title":"Phospho-beta-catenin accumulation in Alzheimer\u2019s disease and in aggresomes attributable to proteasome dysfunction","volume":"25","author":"Ghanevati","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","article-title":"Tau proteins in Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms","volume":"8","author":"Goedert","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0205","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0210","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0002-9440(10)65219-4","article-title":"A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer\u2019s disease","volume":"155","author":"Ghoshal","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0215","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1074\/mcp.M115.050724","article-title":"The Human Tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome","volume":"14","author":"Gunawardana","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0220","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","article-title":"Tauopathies","volume":"64","author":"Hern\u00e1ndez","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0225","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1471-4159.1999.0722053.x","article-title":"p38 kinase is activated in the Alzheimer's disease brain","volume":"72","author":"Hensley","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00401-020-02261-4","article-title":"The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"141","author":"Hondius","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0235","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2353\/ajpath.2009.080814","article-title":"The unfolded protein response is activated in pretangle neurons in Alzheimer\u2019s disease hippocampus","volume":"174","author":"Hoozemans","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","article-title":"The unfolded protein response is activated in Alzheimer\u2019s disease","volume":"110","author":"Hoozemans","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/alz.12198","article-title":"Mitophagy alterations in Alzheimer\u2019s disease are associated with granulovacuolar degeneration and early tau pathology","volume":"17","author":"Hou","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathological assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0260","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9440(10)63465-7","article-title":"Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice","volume":"163","author":"Ishizawa","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.06.024","article-title":"Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration","volume":"463","author":"Kadokura","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0270","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-006-0049-9","article-title":"Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions","volume":"111","author":"Kannanayakal","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00401-016-1562-0","article-title":"Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology","volume":"132","author":"K\u00f6hler","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0280","doi-asserted-by":"crossref","unstructured":"K\u00f6hler C, Dinekov M, G\u00f6tz J (2013) Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice. Neurobiol Aging 34:1369-1379.","DOI":"10.1016\/j.neurobiolaging.2012.11.010"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2014.07.006","article-title":"Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and A\u03b2 amyloidosis","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0295","first-page":"381","article-title":"Alzheimer\u2019s presenile dementia. A histochemical and electron microscopic study","volume":"14","author":"Krigman","year":"1965","journal-title":"Lab Invest"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-006-0159-4","article-title":"Relation of hippocampal phospho-SAPK\/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies","volume":"113","author":"Lagalwar","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0305","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jnr.21072","article-title":"Ectopic expression of phospho-Smad2 in Alzheimer\u2019s disease: uncoupling of the transforming growth factor-beta pathway?","volume":"84","author":"Lee","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010100435","article-title":"The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease","volume":"103","author":"Leroy","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0315","first-page":"228","article-title":"Detection of a Cdc2-related kinase associated with Alzheimer-paired helical filaments","volume":"146","author":"Liu","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005072-198807000-00001","article-title":"Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies","volume":"47","author":"Love","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0325","doi-asserted-by":"crossref","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer\u2019s Association (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123:1-11.","DOI":"10.1007\/s00401-011-0910-3"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0330","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/WNR.0b013e328358720b","article-title":"Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration","volume":"23","author":"Nakamori","year":"2012","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0335","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer\u2019s disease neuropathological changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0340","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/path.3969","article-title":"The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies","volume":"226","author":"Nijholt","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0345","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00296544","article-title":"Reexamination of granulovacuolar degeneration","volume":"82","author":"Okamoto","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0350","first-page":"783","article-title":"An ultrastructural observation on granulovacuolar degenerations in reference to the process of their formation","volume":"26","author":"Oyanagi","year":"1974","journal-title":"Brain Nerve (Tokyo)"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer\u2019s disease","volume":"109","author":"Pei","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0360","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen synthase kinase 3 (GSK-3) in brains staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0365","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/JAD-2001-3107","article-title":"Localization of active forms of c-Jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration","volume":"3","author":"Pei","year":"2001","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-002-0565-1","article-title":"Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration","volume":"104","author":"Pei","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0006-8993(98)00296-0","article-title":"Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration","volume":"797","author":"Pei","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0380","doi-asserted-by":"crossref","unstructured":"Pei JJ, Khatoon S, An WL, Nordlinder M, Tanaka T, Braak H, Tsujio I, Takeda M, Alafuzoff I, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K (2003) Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol 105:381-392.","DOI":"10.1007\/s00401-002-0657-y"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0395","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","article-title":"Activation of extracellular receptor kinase (ERK) in Alzheimer's disease links oxidative stress to abnormal tau phosphorylation","volume":"10","author":"Perry","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0400","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1096\/fj.11-181297","article-title":"Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs","volume":"25","author":"Rudrabhatla","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0405","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/omi.2019.0191","article-title":"Multiplexed phosphoproteomic study of brain in patients with Alzheimer\u2019s disease and age-matched cognitively healthy controls","volume":"24","author":"Sathe","year":"2020","journal-title":"OMICS"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0410","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0197-4580(00)00110-X","article-title":"Casein kinase 1\u03b4 is associated with pathological accumulation of tau in several neurodegenerative diseases","volume":"21","author":"Schwab","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0415","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00005072-199909000-00012","article-title":"In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease","volume":"58","author":"Selznick","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0420","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.jproteome.0c00137","article-title":"Physiological tau interactome in brain and its link to tauopathies","volume":"19","author":"Sinsky","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0425","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65460-0","article-title":"Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer\u2019s disease. Evidence for apoptotic cell death","volume":"155","author":"Stadelmann","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0430","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-981-32-9358-8_13","article-title":"Tau interacting proteins: gaining insight into the roles of Tau in health and disease","volume":"1184","author":"Stancu","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0435","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-002-0548-2","article-title":"Caspase cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer\u2019s disease and Down\u2019s syndrome brain","volume":"104","author":"Su","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0445","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0014-4886(03)00180-8","article-title":"p38MAP kinase is activated at early stages in Alzheimer\u2019s disease brain","volume":"183","author":"Sun","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0450","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer disease brain","volume":"24","author":"Tagawa","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0455","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/pmic.201400171","article-title":"Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome","volume":"15","author":"Tan","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0465","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jnr.21298","article-title":"c-Jun phosphorylation in Alzheimer disease","volume":"85","author":"Thakur","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0470","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00401-011-0871-6","article-title":"Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response","volume":"122","author":"Thal","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0475","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A \u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-150417","article-title":"Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease","volume":"49","author":"Triplett","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0485","doi-asserted-by":"crossref","unstructured":"Ueberham U, Ueberham E, Gruschka H, Arendt T (2006) Altered subcellular location of phosphorylated Smads in Alzheimer\u2019s disease. Eur J Neurosci 24:2327-2334.","DOI":"10.1111\/j.1460-9568.2006.05109.x"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0490","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.jnen.0000218445.30535.6f","article-title":"Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo","volume":"65","author":"Unterberger","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0495","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.17-10-03588.1997","article-title":"Aberrant expression of mitotic cdc2\/cyclin B1 kinase in degenerating neurons of Alzheimer\u2019s disease brain","volume":"17","author":"Vincent","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0500","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-008-0419-6","article-title":"The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome","volume":"116","author":"Wegiel","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0505","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15548627.2019.1680217","article-title":"Granulovacuolar degeneration bodies: red alert for neurons with MAPT\/tau pathology","volume":"16","author":"Wiersma","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0510","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00401-019-02046-4","article-title":"Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology","volume":"138","author":"Wiersma","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0515","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s004010050513","article-title":"Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I\/glycogen synthase kinase-3 and cyclin-dependent kinase 5, a component of TPK II","volume":"92","author":"Yamaguchi","year":"1996","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0520","doi-asserted-by":"crossref","first-page":"e26996","DOI":"10.1371\/journal.pone.0026996","article-title":"Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders","volume":"6","author":"Yamazaki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0525","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2010.04.038","article-title":"Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer\u2019s disease hippocampus","volume":"477","author":"Yamazaki","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0530","doi-asserted-by":"crossref","unstructured":"Zahid S, Oellerich M, Asif AR, Ahmed N (2012) Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients. J Neurochem 121: 954-963.","DOI":"10.1111\/j.1471-4159.2012.07737.x"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0535","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0047-6374(01)00342-6","article-title":"Differential activation of neuronal ERK, JNK\/SAPK and p38 in Alzheimer's disease, the two hit hypothesis","volume":"123","author":"Zhu","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0540","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000067426","article-title":"The role of mitogen-activated protein kinase pathways in Alzheimer's disease","volume":"11","author":"Zhu","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2003.01645.x","article-title":"JKK1, an upstream activator of JNK\/SAPK, is activated in Alzheimer's disease","volume":"85","author":"Zhu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0550","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00046.x","article-title":"Activation and redistribution of c-Jun N-terminal kinase\/stress activated protein kinase in degenerating neurons in Alzheimer's disease","volume":"76","author":"Zhu","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0555","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jnen\/59.10.880","article-title":"Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease","volume":"59","author":"Zhu","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0560","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1471-4159.2001.00597.x","article-title":"Activation of MKK6, an upstream activator of p38, in Alzheimer's disease","volume":"79","author":"Zhu","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2021.10.023_b0565","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1471-4159.2003.01820.x","article-title":"Distribution, levels, and activation of MEK1 in Alzheimer's disease","volume":"86","author":"Zhu","year":"2003","journal-title":"J. Neurochem"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221005340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221005340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:19:16Z","timestamp":1759681156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452221005340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":110,"alternative-id":["S0306452221005340"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.10.023","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}